Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) EBIT : HK$233.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co EBIT?

Beijing Chunlizhengda Medical Instruments Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was HK$105.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$233.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Beijing Chunlizhengda Medical Instruments Co's annualized ROC % for the quarter that ended in Dec. 2023 was 30.92%. Beijing Chunlizhengda Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 48.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Beijing Chunlizhengda Medical Instruments Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.07%.

Beijing Chunlizhengda Medical Instruments Co EBIT Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co EBIT Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

315.78

396.93

471.71

376.25

334.69

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															130.98	-	61.53	105.94	65.55

Competitive Comparison of Beijing Chunlizhengda Medical Instruments Co's EBIT

For the Medical Devices subindustry, Beijing Chunlizhengda Medical Instruments Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Chunlizhengda Medical Instruments Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Chunlizhengda Medical Instruments Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Beijing Chunlizhengda Medical Instruments Co's EV-to-EBIT falls into.

Beijing Chunlizhengda Medical Instruments Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$233.0 Mil.

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Beijing Chunlizhengda Medical Instruments Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	485.784 * ( 1 - 11.53% )	/	( (1548.387	+	1231.682)	/ 2 )
=	429.7731048	/	1390.0345
=	30.92 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3604.173	-	343.681	-	( 1712.105	-	max(0, 519.975	-	2893.506	+	1712.105	))
=	1548.387

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3991.813	-	464.96	-	( 2295.171	-	max(0, 740.131	-	3287.199	+	2295.171	))
=	1231.682

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Beijing Chunlizhengda Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	423.76	/	( ( (518.648 + max(531.296, 0))	+	(508.755 + max(193.694, 0)) )	/	2 )
=	423.76	/	( ( 1049.944	+	702.449 )	/	2 )
=	423.76	/	876.1965
=	48.36 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(571.686	+	446.21	+	33.375)	-	(343.681	+	0	+	176.294)
=	531.296

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(443.96	+	475.232	+	13.297)	-	(464.96	+	0	+	273.835)
=	193.694

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Beijing Chunlizhengda Medical Instruments Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	233.017	/	3836.972
	=	6.07 %

Beijing Chunlizhengda Medical Instruments Co EBIT Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

688236:China

Address

No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN

Website

http://www.clzd.com

Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Citigroup Inc.	2502 Approved lending agent
Fidelity China Special Situations Plc	2101 Beneficial owner
Taiping Assets Management (hk) Company Limited	2102 Investment manager
Taiping Trustees Limited	2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines